Did you miss #CAHR2025 back in May?
Never fear! You can find videos of all the talks and panels on the CAHR YouTube page. 🎊
Check them out, and enjoy!
https://www.youtube.com/@CAHRACRV/videos
0
0
0
0
Hashtag
#CAHR2025
Advertisement · 728 × 90
Grateful to have been asked to deliver the clinical sciences plenary talk at #cahr2025 a couple weeks ago about 'The Promise of PrEP'!
www.youtube.com/watch?v=0xuF...
3
1
0
0
📣 With research areas ranging from the connection between bone marrow and cardiovascular risk in #HIV, educational resources for patients, and the impact of oral #cannabis use on HIV treatment, it was amazing to see CTN+ researchers to take to the stage at #CAHR2025 and share their work.
1
0
0
1
Spring brings new collaborations and connections within the HIV/STBBI research community! 🌱
Held in Halifax this May, #CAHR2025 hosted researchers and community members from health care and research organizations across Canada, including the CTN+.
Check out the highlights:
https://bit.ly/4krQJ0i
1
0
0
1
#CAHR2025 - Content now available and conference wrap up.
Le contenu de l’ #ACRV2025 est maintenant disponible, ainsi que la cérémonie clôture du congrès.
myemail.constantcontact.com/CAHR-2025---...
0
0
0
0
Congratulations to the #CAHR2025 New Investigator Award winners: Celene Titus, Monika Kowatsch, Maureen Owino, Tanya Lazor and Candace Neumann!
5
0
0
1
Really enjoyed connecting with the Canadian HIV community at #CAHR2025! Thanks for opportunity to participate in several sessions on behalf of CIHR and a privilege to present some research results as well 💕
3
0
0
0
Thank you for joining us at #CAHR2025 in Halifax! We wish you safe travels home and hope to see you all next year in Winnipeg.
2
0
0
1
A group of BC-CfE researchers standing in front of the welcome signs at the conclusion of CAHR 2025.
The CAHR 2025 closing presentation welcome people to Manitoba for next year's conference.
And that's a wrap on #CAHR2025!
On behalf of all of the BC-CfE folks (some pictured below), thank you to the @cahr-acrv.bsky.social organizers, volunteers and everyone involved in putting on another wonderful conference!
See you next year in Manitoba!
1
0
0
0
Dr. Katherine Kooij presenting at CAHR 2025.
Dr. Katherine Kooij presenting at CAHR 2025.
Encouragingly, healthy life expectancy is increasing over time (lower among females compared to males), however time spent with chronic age-related disease is also increasing (females were not expected to spend more time than males). #CAHR2025
1
0
0
0
Dr. Katherine Kooij presenting at CAHR 2025.
Our final oral presentation of #CAHR2025, Dr. Katherine Kooij sharing work using #COASTstudy data on age-related life expectancy for those living with HIV, looking at quality of life (free of chronic disease) and whether this differs by sex.
2
0
1
0
Felipe Duailibe presenting at CAHR 2025.
Overall, the results find #PrEP is reaching and supporting those who need it, but PrEP was associated with changes in sexual behaviour that may warrant further sexual health prevention, particularly for b-STIs. #CAHR2025
0
0
0
0
Felipe Duailibe presenting at CAHR 2025.
Felipe Duailibe presenting in the final Epi & Pop Heath session this morning on changing sexual behaviours after initiating #PrEP using #EngageStudy data and examining within-person changes to sexual behaviour rather than between-person. #CAHR2025
0
0
1
0
Evan Barad presenting at CAHR 2025.
Evan Barad presenting at CAHR 2025.
Barad also dug into the phylogeny of HIV sequences present during NSV to examine the clonally expanded proviruses producing NSV. Showing participants that blips occur from these proviruses rather than resistance/non-adherence, helps better guide clinical management. #CAHR2025
2
0
0
0
Fatima Yaseen presenting at CAHR 2025.
Fatima Yaseen presenting at CAHR 2025.
Yaseen’s work examined the incidence/cause of PLLV, finding 10% of the 2800 participants in their study experienced at least 1 episode of PLLV & that 76% couldn’t be explained by drug resistance/non-adherence, indicating it's likely due to clonally-expanded proviruses. #CAHR2025
2
0
1
0
Fatima Yaseen presenting at CAHR 2025.
Evan Barad presenting at CAHR 2025.
Returning to Basic Sciences, Fatima Yaseen & Evan Barad closed out the session with their work looking at persistent low level viremia (PLLV)/non-suppressible viremia (NSV) to help shed light on the reasons for viral load blips. #CAHR2025
2
0
1
0
Alex Korzuchowski presenting at CAHR 2025.
From this work, Korzuchowski found high levels of DAA effectiveness among people living with HIV, but found that problematic alcohol use and methadone dispensation were associated with not achieving SVR suggesting increased HCV treatment among people who use drugs. #CAHR2025
1
0
0
0
Alex Korzuchowski presenting at CAHR 2025.
Over in the Epi & Pop Health session co-moderated by BC-CfE Research Scientist Dr. David Moore, Alex Korzuchowski presented follow-up modelling from his presentation last year, examining the effectiveness of direct acting antiviral (DAA)-era #HCV therapy in BC. #CAHR2025
1
0
1
0
Maggie Duncan presenting at CAHR 2025.
Her comprehensive analysis demonstrated how specific HLA alleles influence the intact HIV reservoir or total proviral burden and how these factors can impact the progression to AIDS if left untreated. #CAHR2025
1
0
0
0
Maggie Duncan presenting at CAHR 2025.
Maggie Duncan kicked off the afternoon Basic Sciences session with her poster-turned-oral presentation looking at how sociodemographic, clinical, and immunogenetic factors impact HIV reservoir size and total proviral burden. #CAHR2025
1
0
1
0
Dr. Surita Parashar presenting at CAHR 2025.
The thematic analysis identified a need for women-only spaces that were safe, accommodating and including supportive staff as key supports to reduce overdose risk. #CAHR2025
1
0
0
0
Dr. Surita Parashar presenting at CAHR 2025.
Through focus group discussions, a major concern voiced by women was lower safety in physical and social environments that led to unsafe use of drugs, and COVID-19 increased the isolation and therefore the risk of overdose experienced by many of the women. #CAHR2025
1
0
1
0
Dr. Surita Parashar presenting at CAHR 2025.
Recognizing the heightened risks women who use drugs experience within the overdose crisis, particularly during COVID-19, Dr. Surita Parashar sharing work that explores overdose risk and care for women living with and without HIV around what supports they need. #CAHR2025
2
0
1
0
Dr. Aki Gormezano presenting at CAHR 2025.
Using a robust analysis, they found increased incidence of b-STIs associated with bareback and ‘party and play’ activities, independent of number of partners. This work highlights the need for emerging prevention interventions like #DoxyPEP in the context of group sex. #CAHR2025
1
0
0
0
Dr. Aki Gormezano presenting at CAHR 2025.
Presenting on back-to-back days, Dr. Aki Gormezano is presenting more #EngageStudy research examining b-STI risk among GBM who engage in group sex and whether the risk is attributed to the number of partners or the habits associated with group sex. #CAHR2025
1
1
1
0
Claudette Cardinal presenting at CAHR 2025.
Claudette always speaks so candidly about her journey and emphasizes the importance of being in tune with how your body responds to HIV medication within your broader healthcare plan, and to advocate for yourself in discussions with your healthcare provider. #CAHR2025
2
0
0
0
Claudette Cardinal presenting at CAHR 2025.
Claudette Cardinal opening up Saturday’s morning sessions speaking about her projects sharing the experiences of Indigenous people living with HIV, and detailing what drives the next phases of her work. #CAHR2025
2
2
1
0
Another CTN+-packed morning at #CAHR2025. Three fantastic presentations from our postdoctoral fellows, the clinical sciences plenary from CTN+ Prevention & Treatment Think Tank Lead Dr. Darrell Tan & the social sciences plenary from CTN+ KM Hub co-lead Dr. Cathy Worthington.
@cahr-acrv.bsky.social
2
0
0
0